Skip to main content

The Governance of New Coronavirus Pandemic: Bridging Research and Policy

Guest edited by:

  • Dr. Hao Li, Global Health Institute, Wuhan University, China
  • Dr. Xinguang Chen, Department of Epidemiology, University of Florida, United States
  • Dr.Don Eliseo Lucero-Prisno III, Department of Global Health and Development, London School of Hygiene & Tropical Medicine, United Kingdom
  • Dr. Abu S. Abdullah, Global Health Research Center, Duke Kunshan University, Kunshan, China

In December 2019, the first patient infected with coronavirus (2019-nCoV, or COVID-19, or SARS-COV-2) was identified in Wuhan, China.   The outbreak developed from a localized epidemic to a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organization and has generated an extensive impact on the world. It is a typical emerging infectious disease that has been found to have a long incubation period and which can be transmitted via droplets, or person-to-person contact, etc. To generate policy recommendations and provide input for different countries to put in place a comprehensive governance framework on the outbreak so as to undertake effective measures, the Global Health Research and Policy (GHRP), through a thematic series, publishes recent progress and findings about the epidemic with the following themes:

  1. Relevant estimation and evaluation models, such as outbreak simulations, disease burden, socioeconomic burden, etc. 
  2. Governance system research, such as multilateral collaboration mechanisms among public and private players.
  3. Health system strengthening, such as the development of an emergency response system, financing, assistance, etc.
  4. Surveillance, public reporting and formulation of relevant laws and regulations 
  5. Comparative study between COVID-19 and SARS, Ebola, MERS, etc. focusing on the prevention and control so as to generate governance policy recommendations
  6. Relevant guidelines at the hospital, community and individual levels
  7. Comprehensive summary of each country’s actions and experience in response to the COVID-19 outbreak and their implications to other countries
  8. Understanding of the impact of the outbreak in China, the globe, and other countries
  9. Other relevant clinical and laboratory research which can generate policy implications

This series was published in Global Health Research and Policy.

Page 2 of 2

  1. The novel coronavirus is a pandemic that has started to creep into Africa thus making the virus a truly global, health security threat. The number of new 2019-nCoV cases has been rising in Africa, though curre...

    Authors: Don Eliseo Lucero-Prisno III, Yusuff Adebayo Adebisi and Xu Lin
    Citation: Global Health Research and Policy 2020 5:21
    Content type: Commentary Published on:

  4. Similar to outbreaks of many other infectious diseases, success in controlling the novel 2019 coronavirus infection requires a timely and accurate monitoring of the epidemic, particularly during its early peri...

    Authors: Xinguang Chen and Bin Yu
    Citation: Global Health Research and Policy 2020 5:7
    Content type: Research Published on:

  5. The novel coronavirus (2019-nCoV, or COVID-19) epidemic first broke out in Wuhan and has been spreading in whole China and the world. The numbers of new infections and deaths in Wuhan are still increasing, whi...

    Authors: Hengbo Zhu, Li Wei and Ping Niu
    Citation: Global Health Research and Policy 2020 5:6
    Content type: Short Report Published on: